Clinical Trials

Inclusion Criteria:

• Patients with physician-diagnosed CRSwNP, with or without comorbid asthma that meet indication criteria for FDA-approved use of Dupixent.
• Patients aged 18 years and older.
• Patient willing to provide consent to be a participant in the study.
• Patients with insurance that allows Dupixent coverage or Dupixent coverage obtained through Dupixent MyWay Program.

Exclusion Criteria:

• Age under 18.
• Suspected or diagnosed allergic fungal rhinosinusitis.
• Suspected or diagnosed cystic fibrosis.
• Dupixent coverage denied through insurance or Dupixent MyWay Program.
• Patients who required a steroid taper in the preceding 30 days. However, patients on chronic steroids equal to ≤ 20 mg of prednisone daily, are eligible.
• Patients who were on a different biologic medication in the preceding 3 months.
• Patients with a diagnosis of EGPA/Churg-Strauss Sydnrome.
• Pregnant patients.
• Patients with inverted papilloma growth.